Another promising target is represented by the Interleukin-3 receptor α chain (IL3Rα/CD123) which is overexpressed on leukemic stem cells and AML blasts compared to normal hematopoietic cells [17]. The gene discussed is IL3RA; the disease is acute myeloid leukemia.